EMEA recommends approvals for two medicines

  The European Medicines Agency is recommending that two new medicines, one of which is a radiopharmaceutical, be granted marketing authorisations. It has also given the go-ahead for new indications for four currently licensed treatments.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom